InMed Pharmaceuticals Inc.
INM
$2.76
$0.010.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.72M | 3.46M | 5.63M | 6.61M | 7.64M |
| Total Receivables | 367.80K | 262.60K | 284.70K | 352.80K | 207.70K |
| Inventory | 814.00K | 1.10M | 1.22M | 1.24M | 1.19M |
| Prepaid Expenses | 507.90K | 644.00K | 148.90K | 477.70K | 1.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.41M | 5.47M | 7.28M | 8.69M | 10.06M |
|
|
|||||
| Total Current Assets | 6.41M | 5.47M | 7.28M | 8.69M | 10.06M |
| Net Property, Plant & Equipment | 1.11M | 1.23M | 1.34M | 1.25M | 1.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.66M | 1.70M | 1.74M | 1.78M | 1.82M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Assets | 9.28M | 8.50M | 10.47M | 11.82M | 13.36M |
|
|
|||||
| Total Accounts Payable | 559.80K | 574.60K | 449.00K | 626.20K | 402.60K |
| Total Accrued Expenses | 846.20K | 784.40K | 560.60K | 986.80K | 726.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 429.20K | 419.70K | 424.30K | 317.80K | 345.50K |
| Total Finance Division Other Current Liabilities | 3.70K | 12.30K | 2.00K | 41.00K | 54.60K |
| Total Other Current Liabilities | 3.70K | 12.30K | 2.00K | 41.00K | 54.60K |
| Total Current Liabilities | 1.84M | 1.79M | 1.44M | 1.97M | 1.53M |
|
|
|||||
| Total Current Liabilities | 1.84M | 1.79M | 1.44M | 1.97M | 1.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 419.30K | 529.20K | 633.80K | 644.90K | 725.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.26M | 2.32M | 2.07M | 2.62M | 2.25M |
|
|
|||||
| Common Stock & APIC | 122.34M | 119.38M | 119.02M | 118.15M | 118.11M |
| Retained Earnings | -115.45M | -113.33M | -110.75M | -109.08M | -107.14M |
| Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
| Total Common Equity | 7.02M | 6.18M | 8.40M | 9.21M | 11.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.02M | 6.18M | 8.40M | 9.21M | 11.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.02M | 6.18M | 8.40M | 9.21M | 11.10M |
|
|
|||||